EFG Asset Management Americas Corp. Boosts Stake in Axon Enterprise, Inc $AXON

EFG Asset Management Americas Corp. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 32.4% in the second quarter, Holdings Channel reports. The institutional investor owned 3,473 shares of the biotechnology company’s stock after acquiring an additional 849 shares during the quarter. EFG Asset Management Americas Corp.’s holdings in Axon Enterprise were worth $2,875,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hemington Wealth Management increased its stake in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 17 shares in the last quarter. Whipplewood Advisors LLC lifted its holdings in Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after purchasing an additional 27 shares in the last quarter. NewSquare Capital LLC lifted its stake in shares of Axon Enterprise by 96.2% in the second quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after buying an additional 25 shares in the last quarter. Washington Trust Advisors Inc. lifted its stake in shares of Axon Enterprise by 44.7% in the second quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock worth $46,000 after buying an additional 17 shares in the last quarter. Finally, TCTC Holdings LLC boosted its position in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on AXON shares. Northland Securities set a $800.00 price objective on shares of Axon Enterprise in a report on Tuesday, August 5th. Raymond James Financial reaffirmed an “outperform” rating and issued a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. UBS Group dropped their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $870.00 price target on shares of Axon Enterprise in a report on Wednesday, September 24th. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $814.00.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 100 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $752.54, for a total value of $75,254.00. Following the completion of the sale, the director owned 1,416 shares in the company, valued at approximately $1,065,596.64. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 38,622 shares of company stock valued at $26,439,364. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $531.09 on Thursday. The firm has a market cap of $41.91 billion, a PE ratio of 131.13, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52 week low of $469.24 and a 52 week high of $885.91. The business’s fifty day simple moving average is $690.64 and its 200-day simple moving average is $733.23.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.46). The company had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm’s quarterly revenue was up 30.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 earnings per share. Equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.